ER-Positive Metastatic Breast Cancer Research Update - 2025-2024 EMBRACE Virtual Forum Series
Dana-Farber Cancer Institute via YouTube
PowerBI Data Analyst - Create visualizations and dashboards from scratch
The Private Equity Associate Certification
Overview
AI, Data Science & Cloud Certificates from Google, IBM & Meta — 40% Off
One plan covers every Professional Certificate on Coursera. 40% off Coursera Plus Annual.
Unlock All Certificates
Join this 57-minute medical webinar where Dr. Erica Mayer and Dr. Antonio Giordano from Dana-Farber Cancer Institute explore the latest advances in research and treatment approaches for patients with ER-positive metastatic breast cancer. Discover cutting-edge therapeutic developments, emerging treatment protocols, and current research findings that are shaping the management of hormone receptor-positive metastatic breast cancer. Learn about new clinical trial results, innovative drug combinations, and evolving treatment strategies that offer hope for improved outcomes in this patient population. Gain insights into the current landscape of ER-positive metastatic breast cancer care and understand how recent scientific breakthroughs are being translated into clinical practice to benefit patients and their families.
Syllabus
ER-Positive MBC Research Update | 2025-2024 EMBRACE MBC Virtual Forum Series
Taught by
Dana-Farber Cancer Institute